Y effect of anti-IgM stimulation on IL-10 production by B cells
Y effect of anti-IgM stimulation on IL-10 production by B cells , whereas other studies , constant with our study, showed a synergistic impact of anti-BCR or anti-BCR + CpG…
Y effect of anti-IgM stimulation on IL-10 production by B cells , whereas other studies , constant with our study, showed a synergistic impact of anti-BCR or anti-BCR + CpG…
Spectively. Conclusions: Serum anti-p53 antibody positivity did not predict chemoresistance in mCRC treated with fluoropyrimidine, oxaliplatin, plus bevacizumab as first-line chemotherapy. Search phrases: Anti-p53 antibody, KRAS, Metastatic colorectal cancer, First-line…